The impact of age on the epidemiology of atrial fibrillation hospitalizations
- PMID: 24332722
- PMCID: PMC4436031
- DOI: 10.1016/j.amjmed.2013.10.005
The impact of age on the epidemiology of atrial fibrillation hospitalizations
Abstract
Background: Given that 4 million individuals in the United States have atrial fibrillation, understanding the epidemiology of this disease is crucial. We sought to identify and characterize the impact of age on national atrial fibrillation hospitalization patterns.
Methods: The study sample was drawn from the 2009-2010 Nationwide Inpatient Sample. Patients hospitalized with a principal International Classification of Diseases, 9th Revision discharge diagnosis of atrial fibrillation were included. Patients were categorized as "older" (≥65 years) or "younger" (<65 years) for the purposes of analysis. The outcomes measured included hospitalization rate, length of stay, in-hospital mortality, and discharge status.
Results: We identified 192,846 atrial fibrillation hospitalizations. There was significant geographic variation in hospitalizations for both younger and older age groups. States with high hospitalizations differed from those states known to have high stroke mortality. Younger patients (33% of the sample) were more likely to be obese (21% vs 8%, P < .001) and to use alcohol (8% vs 2%, P < .001). Older patients were more likely to have kidney disease (14% vs 7%, P < .001). Both age groups had high rates of hypertension and diabetes. Older patients had higher in-hospital mortality and were more likely to be discharged to a nursing or intermediate care facility.
Conclusions: Younger patients account for a substantial minority of atrial fibrillation hospitalizations in contemporary practice. Younger patients are healthier, with a different distribution of risk factors, than older patients who have higher associated morbidity and mortality.
Keywords: Age; Atrial fibrillation; Epidemiology.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
Sahar Naderi, MD MHS: no conflicts of interest
Yun Wang, PhD: no conflicts of interest
Amy L. Miller, MD PhD: no conflicts of interest
Fátima Rodriguez, MD MPH: no conflicts of interest
Mina K. Chung, MD: no conflicts of interest
Martha J. Radford, MD: no conflicts of interest
JoAnne M. Foody, MD: no conflicts of interest
Figures



References
-
- Camm J. Atrial fibrillation--an end to the epidemic? Circulation. 2005;112:iii. - PubMed
-
- Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–1457. - PubMed
-
- Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952. - PubMed
-
- Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA: the journal of the American Medical Association. 2001;285:2370–2375. - PubMed
-
- Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4:313–320. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical